Funding Announcements Percussion Rhythmyx braininfo@ninds.nih.gov Copyright 2008, National Institute of Neurological Disorders and Stroke Saturday Sunday http://blogs.law.harvard.edu/tech/rss http://www.ninds.nih.gov/funding/funding_announcements/allcurrent.htm This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose to develop new non-animal-based assays to assess the potency of botulinum neurotoxin type A (BoNT/A) in a Good Manufacturing Practice (GMP) commercial environment. Successful projects should have as their goal the development of a test(s) and reagents that could be used for commercial release testing of BoNT/A products. http://www.ninds.nih.gov/funding/funding_announcements/pa/PA-09-178.htm http://www.ninds.nih.gov/funding/funding_announcements/pa/PA-09-178.htm This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop new non-animal-based assays to assess the potency of botulinum neurotoxin type A (BoNT/A) in a Good Manufacturing Practice (GMP) commercial environment. Successful projects should have as their goal the development of a test(s) and reagents that could be used for commercial release testing of BoNT/A products. http://www.ninds.nih.gov/funding/funding_announcements/pa/PA-09-179.htm http://www.ninds.nih.gov/funding/funding_announcements/pa/PA-09-179.htm This is a time-sensitive Request for Information (RFI) issued by the National Institute of Neurological Disorders and Stroke. The information requested is meant to ascertain the needs for clinical databases and linked biorepositories to advance clinical and translational research in Parkinson’s disease. The Institute envisions such an effort as serving the data sharing and data integration needs of the wider research community including industry, non-profit Parkinson’s disease-related organizations, and the research activities of other NIH Institutes and Federal agencies including the Veterans Administration and the Department of Defense. The responses to the RFI will be collected by various Institute staff to assess how best to meet the needs of researchers in the field and will be made available to the public. http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-NS-09-010.htm http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-NS-09-010.htm This NIH Funding Opportunity Announcement (FOA) is supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5. The purpose of the Academic Research Enhancement Award (AREA) program is to stimulate research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation's research scientists, but that have not been major recipients of NIH support. These AREA grants create opportunities for scientists and institutions otherwise unlikely to participate extensively in NIH programs, to contribute to the Nation's biomedical and behavioral research effort. AREA grants are intended to support small-scale health-related research projects proposed by faculty members of eligible, domestic institutions. Mechanism of Support. This FOA will utilize the Academic Research Enhancement Award (AREA) R15 award mechanism. http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-OD-09-007.htm http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-OD-09-007.htm This NIH Funding Opportunity Announcement (FOA), supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5, invites applications from U.S academic institutions/organizations to support the hiring of newly-recruited faculty to develop research projects within the context of Biomedical Core Centers. For this announcement, a Biomedical Core Center is defined as a community of multidisciplinary researchers focusing on areas of biomedical research relevant to NIH, such as centers, departments, programs, and/or trans-departmental collaborations or consortia. . These awards are designed to enhance innovative programs of excellence by providing scientific and programmatic support for promising research faculty and their areas of research. Specifically for the purposes of this announcement, Core Center Grants are institutional awards that provide funding to hire, provide appropriate start-up packages, and develop pilot research projects for newly independent investigators, with the goal of augmenting and expanding the institution’s community of multidisciplinary researchers focusing on areas of biomedical research relevant to NIH. http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-OD-09-005.htm http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-OD-09-005.htm This NIH Funding Opportunity Announcement (FOA), supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5, solicits applications for the following topic areas relevant to research on the heterogeneity of Autism Spectrum Disorders (ASD): Measurement development, Biomarkers/biological signatures, Immune and central nervous systems interactions, Genetics/genomics, Environmental Risk Factors, Model development, Treatment and intervention, and Services research. This FOA provides support for the R01 grant mechanism which supports larger scale studies for which preliminary data exists and proof-of-principle has been established. http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-MH-09-170.htm http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-MH-09-170.htm This NIH Funding Opportunity Announcement (FOA), supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5, solicits applications for the following topic areas relevant to research on the heterogeneity of Autism Spectrum Disorders (ASD): Measurement development, Biomarkers/biological signatures, Immune and central nervous systems interactions, Genetics/genomics, Environmental Risk Factors, Model development, Treatment and intervention, and Services research. This FOA provides support for the R21 grant mechanism which supports initial technical development and proof-of-principle and research in exploratory or preliminary phases. The R21 mechanism is intended to encourage new exploratory and developmental research projects where preliminary data are not required. http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-MH-09-172.htm http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-MH-09-172.htm This NIH Funding Opportunity Announcement (FOA), supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5, solicits through this limited competition applications from domestic (United States) institutions/organizations proposing to develop and implement critical research innovations to advance the research enterprise, stimulate future growth and investments, and advance public health and health care delivery. The purpose of the “GO” grants program is to support high impact ideas that lend themselves to short-term funding, and may lay the foundation for new fields of investigation. The “GO” grants program will support large-scale research projects that accelerate critical breakthroughs, early and applied research on cutting-edge technologies, and new approaches to improve the synergy and interactions among multi and interdisciplinary research teams. The initiative seeks novel approaches in areas that address specific knowledge gaps, scientific opportunities, new technologies, data generation, or research methods that would benefit from an influx of funds to quickly advance the area in significant ways. Applicants may propose to address either a specific research question or propose the creation of a unique infrastructure/resource designed to accelerate scientific progress in the future. This program is a trans-NIH effort supported by Recovery Act funds. For those projects that span the missions of Institutes, Centers and Offices (ICs), support may come from Recovery Act funds allocated to the Common Fund. http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-OD-09-004.htm http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-OD-09-004.htm The purpose of this program is to provide researchers supplementary funds that can be used to accelerate the tempo of scientific research on active grants, with the ultimate goal of promoting job creation and economic development. The program allows investigators with active NINDS funding to submit competitive revision applications that extend the scope of their currently approved projects. Support for these supplements will come from funds available through the American Recovery and Reinvestment Act of 2009 (ARRA). http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-OD-09-058.htm http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-OD-09-058.htm The overall purpose of the supplement programs is to provide researchers additional funds that can be used to accelerate the tempo of scientific research on active grants, with the ultimate goal of promoting job creation and economic development. Summer Research Experience supplements will specifically encourage students to pursue research careers in the health related sciences, and provide elementary, middle school, and high school teachers, community college faculty, and faculty from non-research intensive institutions with short-term research experiences in NIH-funded laboratories. http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-OD-09-060.htm http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-OD-09-060.htm The purpose of this program is to provide researchers supplementary funds that can be used to accelerate the tempo of scientific research on active grants, with the ultimate goal of promoting job creation and retention and economic development. The program allows investigators and institutions with active NIH funding to request administrative supplements to increase the pace of currently approved and funded projects. Support for these supplements will come from funds available through the ARRA. http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-OD-09-056.htm http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-OD-09-056.htm The National Institutes of Health (NIH) and the National Aeronautics and Space Administration (NASA) are cooperating to facilitate biomedical research in space for better understanding of human physiology and human health on Earth. The NIH uses this FOA to publicize the availability of the International Space Station (ISS) as a National Laboratory, and to announce the NIH BioMed-ISS program encouraging investigator-initiated applications for biomedical research that will use the unique microgravity and radiation environment and resources of the ISS to test innovative hypotheses for the potential benefit of human health on Earth. Applications to this FOA should propose innovative biomedical research on the molecular or cellular level that is directly relevant to the NIH mission and can be carried out on the ISS. http://www.ninds.nih.gov/funding/funding_announcements/pa/PAR-09-120.htm http://www.ninds.nih.gov/funding/funding_announcements/pa/PAR-09-120.htm